EGFR – EXON 20INS: Καρκίνος του Πνεύμονα

(4:34)

EGFR+: Καρκίνος του Πνεύμονα

(2:52)

Afatinib inhibits EGFR Receptor activation

(17)

Dr. Garassino on Immunotherapy in EGFR-Mutated Lung Cancer

(1:7)

EGFR Exon-20 Mutation - Lung Cancer Video Library

(4:41)

EGFR Mechanisms of Resistance

(8:37)

EGFR Mutations in Patients With Lung Cancer

(1:41)

Overview of the world of EGFR mutant lung cancers

(3:38)

Therapeutic strategies for EGFR-mutated lung cancer

(2:23)

Current Role of Immunotherapy in EGFR-Mutant Lung Cancer

(48)

Dr. Gitlitz on EGFR Exon 20 Insertion Mutations in Lung Cancer

(1:11)

Selecting EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Lung Cancer

(52)

Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC

(2:36)

What is EGFR and the EGFR Mutation?

(1:59)

Treating Patients With EGFR-Mutant Lung Cancer With Targeted Therapies

(50)

Identification of EGFR Mutations Impact Overall Prognosis in Lung Cancers

(1:13)

NGS Vs PCR for EGFR genotyping in NSCLC

(42)

Case 2: Testing for EGFR in Lung Adenocarcinoma

(5:)

Patient Summary: EGFR-Mutant Stage 4 Lung Adenocarcinoma

(2:19)

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

(4:25)